The Current Ratio as of December 2024 (TTM) for Alimera Sciences, Inc. (ALIM) is 2.79

According to Alimera Sciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.79. This represents a change of 6.03% compared to the average of 2.63 of the last 4 quarters.

Alimera Sciences, Inc. (ALIM) Historical Current Ratio (quarterly & annually)

How has ALIM Current Ratio performed in the past?

The mean historical Current Ratio of Alimera Sciences, Inc. over the last ten years is 3.38. The current 2.79 Current Ratio has changed 8.17% with respect to the historical average. Over the past ten years (40 quarters), ALIM's Current Ratio was at its highest in in the December 2014 quarter at 7.95. The Current Ratio was at its lowest in in the December 2022 quarter at 0.74.

Alimera Sciences, Inc. (ALIM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alimera Sciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alimera Sciences, Inc. (ALIM) Average Current Ratio

How has ALIM Current Ratio performed in the past?

The current Current Ratio of Alimera Sciences, Inc. (ALIM) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Alimera Sciences, Inc. (ALIM) Current Ratio vs. Peers

How is ALIM’s Current Ratio compared to its peers?

Alimera Sciences, Inc.’s Current Ratio is greater than Shuttle Pharmaceuticals Holdings, Inc. (0.22), greater than Lifecore Biomedical, Inc. (1.83), greater than Mallinckrodt plc (2.74), greater than Journey Medical Corporation (1.38), greater than Lucy Scientific Discovery Inc. (0.38), greater than Adamis Pharmaceuticals Corporation (0.58), less than Organogenesis Holdings Inc. (3.09), greater than Cyclo Therapeutics, Inc. (0.17), greater than Athenex, Inc. (1.09), greater than MedMen Enterprises Inc. (0.49), greater than China Pharma Holdings, Inc. (0.79), greater than Halo Collective Inc. (1.40), greater than China SXT Pharmaceuticals, Inc. (1.60), greater than Petros Pharmaceuticals, Inc. (0.85),

Build a custom stock screener for Alimera Sciences, Inc. (ALIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alimera Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alimera Sciences, Inc. (ALIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alimera Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.